Viral Detection Market Report – Research, Industry Analysis Reports and Market Demands

Global Viral Detection Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Viral Detection Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Viral Detection by Company Revenue
- 3.2.2 Top 3 Viral Detection Players Market Share in 2025
- 3.2.3 Top 6 Viral Detection Players Market Share in 2025
3.3 Viral Detection Market: Overall Company Footprint Analysis
- 3.3.1 Viral Detection Market: Region Footprint
- 3.3.2 Viral Detection Market: Company Product Type Footprint
- 3.3.3 Viral Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Viral Detection Consumption Value and Market Share by Type (2021-2026)
4.2 Global Viral Detection Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Viral Detection Consumption Value Market Share by Application (2021-2026)
5.2 Global Viral Detection Market Forecast by Application (2027-2032)

6 North America

6.1 North America Viral Detection Consumption Value by Type (2021-2032)
6.2 North America Viral Detection Market Size by Application (2021-2032)
6.3 North America Viral Detection Market Size by Country
- 6.3.1 North America Viral Detection Consumption Value by Country (2021-2032)
- 6.3.2 United States Viral Detection Market Size and Forecast (2021-2032)
- 6.3.3 Canada Viral Detection Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Viral Detection Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Viral Detection Consumption Value by Type (2021-2032)
7.2 Europe Viral Detection Consumption Value by Application (2021-2032)
7.3 Europe Viral Detection Market Size by Country
- 7.3.1 Europe Viral Detection Consumption Value by Country (2021-2032)
- 7.3.2 Germany Viral Detection Market Size and Forecast (2021-2032)
- 7.3.3 France Viral Detection Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Viral Detection Market Size and Forecast (2021-2032)
- 7.3.5 Russia Viral Detection Market Size and Forecast (2021-2032)
- 7.3.6 Italy Viral Detection Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Viral Detection Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Viral Detection Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Viral Detection Market Size by Region
- 8.3.1 Asia-Pacific Viral Detection Consumption Value by Region (2021-2032)
- 8.3.2 China Viral Detection Market Size and Forecast (2021-2032)
- 8.3.3 Japan Viral Detection Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Viral Detection Market Size and Forecast (2021-2032)
- 8.3.5 India Viral Detection Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Viral Detection Market Size and Forecast (2021-2032)
- 8.3.7 Australia Viral Detection Market Size and Forecast (2021-2032)

9 South America

9.1 South America Viral Detection Consumption Value by Type (2021-2032)
9.2 South America Viral Detection Consumption Value by Application (2021-2032)
9.3 South America Viral Detection Market Size by Country
- 9.3.1 South America Viral Detection Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Viral Detection Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Viral Detection Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Viral Detection Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Viral Detection Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Viral Detection Market Size by Country
- 10.3.1 Middle East & Africa Viral Detection Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Viral Detection Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Viral Detection Market Size and Forecast (2021-2032)
- 10.3.4 UAE Viral Detection Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Viral Detection Market Drivers
11.2 Viral Detection Market Restraints
11.3 Viral Detection Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Viral Detection Industry Chain
12.2 Viral Detection Upstream Analysis
12.3 Viral Detection Midstream Analysis
12.4 Viral Detection Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Viral Detection market size was valued at US$ 934 million in 2025 and is forecast to a readjusted size of US$ 2484 million by 2032 with a CAGR of 14.9% during review period.
Viral Detection refers to viral safety testing services performed for biologics, vaccines, recombinant proteins, monoclonal antibodies, cell therapies, gene therapies, as well as their raw materials, cell banks, virus seed stocks, unprocessed bulk harvests, and final product lots. It is not a single physical device; rather, it is an integrated quality-control service package composed of testing strategies, standard operating procedures, sample receipt and preparation workflows, indicator cell lines, nucleic-acid amplification systems, sequencing platforms, electron microscopy platforms, reference controls, data-analysis pipelines, and compliant reporting. Its major categories include cell-based in vitro assays, molecular methods such as PCR, qPCR, and ddPCR, broad-range NGS screening, TEM-based morphological identification, and dedicated assays for replication-competent AAV, replication-competent lentivirus, retroviruses, and related viral risks. The technical principle is to identify known or unknown viral contaminants in different sample matrices through viral growth effects, characteristic nucleic-acid sequences, particle morphology, host-range response, and orthogonal confirmation, then determine whether exogenous viral introduction or amplification risks exist in the manufacturing process. This service is mainly provided by CROs, contract testing laboratories, CDMOs with in-house quality platforms, and specialized biologics safety testing organizations. Its key technical requirements focus on sensitivity, specificity, coverage breadth, sample compatibility, contamination control, regulatory compliance, and robust GMP/GLP system execution. Typical use scenarios include cell bank release, raw material release, in-process control, unprocessed bulk testing, final lot release, and contamination investigation.
The expansion of the Viral Detection market is primarily driven by the continued growth of biologics, cell therapies, gene therapies, and novel vaccines. As product complexity rises, a single analytical method is no longer sufficient to cover all viral-risk scenarios, which is accelerating the combined use of cell-based assays, molecular methods, NGS, and electron microscopy. At the same time, updated regulatory frameworks such as ICH Q5A(R2) are bringing risk-based strategies, sample-tiering logic, animal-free alternatives, and faster release concepts to the forefront, pushing Viral Detection from a “pre-submission compliance task” toward a continuous quality system spanning cell banking, raw materials, process control, lot release, and deviation investigation. For downstream users, building an internal high-grade viral safety platform requires heavy capital, long validation timelines, and difficult maintenance; therefore, outsourcing to specialized organizations with GMP/GLP systems, established methods, and regulatory communication experience has become a practical route to improve efficiency, shorten timelines, and reduce compliance risk.
The main market challenge is no longer whether testing is required, but how to balance accuracy, coverage, speed, cost, and regulatory acceptance. Traditional in vitro and in vivo assays provide broad coverage, but their timelines are longer and sample compatibility can be limited. PCR-based methods are fast and sensitive, but they do not fully address unknown viral threats. NGS is growing rapidly, yet it places higher demands on data interpretation, background-noise control, contamination tracing, method validation, and cross-batch consistency. In cell and gene therapy, complex sample matrices, vector-related signals, and specialized replication-competent virus risks further increase the difficulty of method development and orthogonal confirmation. The industry also faces practical constraints such as cross-region regulatory differences, scheduling bottlenecks, limited expert capacity, and high biosafety requirements. Future competition will therefore center not only on the number of tests offered, but also on platform strength, regulatory alignment, turnaround time, and investigation capability.
Downstream demand is shifting from isolated testing items toward lifecycle-wide testing portfolios. Historically, demand was concentrated on foundational release testing for cell banks and raw materials. Now, more programs are moving Viral Detection upstream into vector construction, donor-material screening, process monitoring, and contamination root-cause tracing, while also extending it downstream into commercial-stage ongoing quality surveillance. Monoclonal antibodies, recombinant proteins, and vaccines remain the most stable demand base, whereas cell therapies, viral vectors, RNA therapeutics, and complex bioprocesses represent the most elastic sources of incremental demand. Supplier selection is also evolving: customers are looking beyond price and increasingly prioritizing integrated capabilities that combine risk assessment, method development, GMP testing, deviation investigation, and global filing support. This will continue to push the market toward platformization, globalization, and higher-value services.
This report is a detailed and comprehensive analysis for global Viral Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Viral Detection market size and forecasts, in consumption value ($ Million), 2021-2032
Global Viral Detection market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Viral Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Viral Detection market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Viral Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Viral Detection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Charles River Laboratories, Eurofins, SGS, Sartorius, Asahi Kasei, Samsung Biologics, Syngene, Intertek, Minaris Advanced Therapies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Viral Detection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Plaque Assays
PCR
ELISA
Others
Market segment by Service Delivery Format
Standard Testing Services
Customized Method Development Services
Validation Services
Batch Release Testing Services
Investigation Services
Others
Market segment by Sample Matrix
Raw Materials
Cell Banks
Viral Seed Stocks / Viral Vectors
In-Process Samples
Bulk Harvest / Drug Substance
Final Product
Others
Market segment by Compliance Level
Research Use Only
Non-GLP / Non-GMP Testing
GLP-compliant Testing
GMP-compliant Testing
Regulatory Submission Support Testing
Others
Market segment by Application
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics
Market segment by players, this report covers
Merck KGaA
Charles River Laboratories
Eurofins
SGS
Sartorius
Asahi Kasei
Samsung Biologics
Syngene
Intertek
Minaris Advanced Therapies
Texcell
PathoQuest
Clean Cells
Avance Biosciences
Microbiologics
Alcami
Creative Biolabs
Creative Biogene
WuXi AppTec
WuXi Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Viral Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Viral Detection, with revenue, gross margin, and global market share of Viral Detection from 2021 to 2026.
Chapter 3, the Viral Detection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Viral Detection market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Viral Detection.
Chapter 13, to describe Viral Detection research findings and conclusion.

Buy now